A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight
Clinical trial NCT06962280 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06962280
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-12
- Primary completion
- 2026-11-01
- Enrollment
- 465
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.